These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look. Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371 [No Abstract] [Full Text] [Related]
23. [Modern trends in the therapy of malignant melanoblastoma (author's transl)]. Richter J; Duchková H; Rus J; Kubíková M Cas Lek Cesk; 1976 Nov; 115(45):1385-9. PubMed ID: 1000546 [No Abstract] [Full Text] [Related]
24. [The present status of the multidisciplinary treatment of malignant melanoma]. Ishihara K; Hayasaka K; Ikegawa S; Kageshita T Gan No Rinsho; 1985 Jul; 31(9 Suppl):1073-8. PubMed ID: 4057571 [TBL] [Abstract][Full Text] [Related]
25. [Evolution of the principles of the treatment in melanoma of the skin (based on the records of the P. A. Hertzen Oncologic Research Institute in Moscow)]. Demidov VP; Ostrovtsev LD; Zhukov VM; Fomin AIu Sov Med; 1989; (3):60-5. PubMed ID: 2660307 [No Abstract] [Full Text] [Related]
26. [Treatment of malignant melanoblastoma of the skin]. Oldhoff J; Koudstaal J; van Goch JJ Ned Tijdschr Geneeskd; 1968 Aug; 112(32):1433-8. PubMed ID: 5679594 [No Abstract] [Full Text] [Related]
32. [Immunotherapy of malignant melanomas]. Macher E Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638 [No Abstract] [Full Text] [Related]
33. [Therapy of metastatic melanoma]. Babović N; Jelić S; Popov I Srp Arh Celok Lek; 2000; 128(7-8):284-9. PubMed ID: 11089438 [No Abstract] [Full Text] [Related]
34. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations]. Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ; Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904 [No Abstract] [Full Text] [Related]
35. [Medical therapy of malignant melanoma]. Mini E; Periti P Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710 [No Abstract] [Full Text] [Related]
36. New therapies for malignant melanoma. Hancock B Practitioner; 1989 Oct; 233(1477):1385-6, 1388. PubMed ID: 2482487 [TBL] [Abstract][Full Text] [Related]
37. Advances in the treatment of late stage melanoma. Walkington LA; Lorigan P; Danson SJ BMJ; 2013 Mar; 346():f1265. PubMed ID: 23460638 [No Abstract] [Full Text] [Related]
38. [Current state of the treatment of melanoma]. Trapeznikov NN; Iavorskiĭ VV; Shirin DF Klin Med (Mosk); 1971 Mar; 49(3):12-7. PubMed ID: 4935012 [No Abstract] [Full Text] [Related]
39. Results of adjuvant BCG immunotherapy in malignant melanoma. Wätzig V; Knopf B Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442 [TBL] [Abstract][Full Text] [Related]